Aboian Mariam S, Junna Mithri R, Krecke Karl N, Wirrell Elaine C
Mayo Medical School, Rochester, Minnesota, USA.
Pediatr Neurol. 2009 Sep;41(3):226-8. doi: 10.1016/j.pediatrneurol.2009.03.007.
Neither intrathecal methotrexate nor posterior reversible encephalopathy syndrome has previously been reported to result in mesial temporal sclerosis. Described here is the case of a boy with no risk factors for mesial temporal sclerosis who presented with posterior reversible encephalopathy syndrome and partial complex seizures 8 days after initiation of intrathecal methotrexate for treatment of Burkitt lymphoma, and who ultimately progressed to intractable temporal lobe epilepsy due to left mesial temporal sclerosis.
此前尚无鞘内注射甲氨蝶呤或后部可逆性脑病综合征导致内侧颞叶硬化的报道。本文描述了一名无内侧颞叶硬化危险因素的男孩的病例,该男孩在接受鞘内注射甲氨蝶呤治疗伯基特淋巴瘤8天后出现后部可逆性脑病综合征和部分性癫痫发作,最终因左侧内侧颞叶硬化进展为难治性颞叶癫痫。